Clinical Trial Update: Observational Study With InnoLet® in Daily Clinical Practice

View source ↗

Summary

Observational study evaluating the InnoLet insulin pen in daily clinical practice. The study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus
• Type 2 Diabetes Mellitus

Drugs mentioned

• InnoLet®

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Diabetes, Diabetes Mellitus, Type 1 | Status: COMPLETED